Carl Zeiss Meditec AG announced that CEO of Carl Zeiss Meditec AG, Dr. Ludwin Monz, has announced to the Supervisory Board that he will not be accepting another term in office. The Supervisory Board notes his decision with regret. Dr. Monz and the Supervisory Board agreed to end his term on 31 December 2021. The Supervisory Board has appointed Dr. Markus Weber the new CEO of Carl Zeiss Meditec AG effective 1 January 2022. As a member of the Executive Board of Carl Zeiss AG, he is currently responsible for the Semiconductor Manufacturing Technology segment and will relinquish his current duties on 31 December 2021. Dr. Markus Weber earned his undergraduate degrees and his doctorate at the universities of Karlsruhe and Ulm. In 2019, Dr. Weber was appointed a member of the Executive Board of Carl Zeiss AG. He assumed responsibility for the ZEISS Semiconductor Manufacturing Technology segment, for the Shared Production Unit and for the Korea sales region.